ProShare Advisors’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,398
Closed -$25.8K 2140
2025
Q1
$25.8K Sell
2,398
-526
-18% -$6.44K ﹤0.01% 2018
2024
Q4
$37.4K Buy
2,924
+649
+29% +$12.9K ﹤0.01% 2216
2024
Q3
$62.8K Buy
2,275
+326
+17% +$9.58K ﹤0.01% 1951
2024
Q2
$56.5K Sell
1,949
-500
-20% -$23.8K ﹤0.01% 1735
2024
Q1
$109K Buy
2,449
+208
+9% +$8.91K ﹤0.01% 1808
2023
Q4
$86.9K Buy
2,241
+293
+15% +$10.6K ﹤0.01% 1800
2023
Q3
$57.3K Buy
1,948
+12
+0.6% +$570 ﹤0.01% 1701
2023
Q2
$123K Buy
1,936
+52
+3% +$2.88K ﹤0.01% 1660
2023
Q1
$88.9K Sell
1,884
-260
-12% -$13.9K ﹤0.01% 1609
2022
Q4
$149K Buy
2,144
+148
+7% +$14.7K ﹤0.01% 1565
2022
Q3
$293K Buy
1,996
+66
+3% +$8.94K ﹤0.01% 1170
2022
Q2
$251K Sell
1,930
-707
-27% -$72.2K ﹤0.01% 1320
2022
Q1
$267K Buy
2,637
+686
+35% +$83.1K ﹤0.01% 1706
2021
Q4
$302K Buy
+1,951
New +$435K ﹤0.01% 1785

Other funds holding LYEL